{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:28:49Z","timestamp":1761560929380},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2004,11,16]],"date-time":"2004-11-16T00:00:00Z","timestamp":1100563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/s00228-004-0831-3","type":"journal-article","created":{"date-parts":[[2004,11,15]],"date-time":"2004-11-15T21:28:49Z","timestamp":1100554129000},"page":"693-701","source":"Crossref","is-referenced-by-count":13,"title":["Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation"],"prefix":"10.1007","volume":"60","author":[{"given":"V. H. M.","family":"Deneer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lie-A-Huen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"Kingma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"Proost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Gossen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Stuurman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. M. M.","family":"UytdeHaag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. H. J. M.","family":"Dunselman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R. B. J.","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,11,16]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0002-9149(89)90253-1","volume":"63","author":"MJ Suttorp","year":"1989","unstructured":"Suttorp MJ, Kingma JH, Lie-A-Huen L, Mast EG (1989) Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. Am J Cardiol 63:693?696","journal-title":"Am J Cardiol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/0735-1097(90)90326-K","volume":"16","author":"MJ Suttorp","year":"1990","unstructured":"Suttorp MJ, Kingma JH, Jessurun ER, Lie-A-Huen L, Van Hemel NM, Lie KI (1990) The value of class Ic antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation to sinus rhythm. J Am Coll Cardiol 16:1722?1727","journal-title":"J Am Coll Cardiol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0002-9149(80)80014-2","volume":"45","author":"B Margolis","year":"1980","unstructured":"Margolis B, De Silva RA, Lown B (1980) Episodic drug treatment in the management of paroxysmal arrhythmia. Am J Cardiol 45:621?626","journal-title":"Am J Cardiol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-94-011-1816-3_8","volume-title":"Atrial fibrillation, a treatable disease?","author":"L Lie-A-Huen","year":"1992","unstructured":"Lie-A-Huen L, Kingma JH (1992) Episodic treatment of paroxysmal atrial fibrillation. In: Kingma JH, Van Hemel NM, Lie KI (ed) Atrial fibrillation, a treatable disease? Kluwer, Dordrecht, pp 149?157"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1053\/euhj.2001.2983","volume":"22","author":"V Fuster","year":"2001","unstructured":"Fuster V, Ryd\u00e9n LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prytowsky EN, Wann LS, Wyse DG (2001) ACC\/AHA\/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. Eur Heart J 22:1852?1923","journal-title":"Eur Heart J"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0002-8703(87)90500-X","volume":"114","author":"AWF Hamer","year":"1987","unstructured":"Hamer AWF, Tanasescu DE, Marks JW, Peter T, Waxman AD, Mandel WJ (1987) Failure of episodic high-dose oral verapamil therapy to convert supraventricular tachycardia: a study of plasma verapamil levels and gastric motility. Am Heart J 114:334?342","journal-title":"Am Heart J"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/clpt.1986.145","volume":"40","author":"DM Salerno","year":"1986","unstructured":"Salerno DM, Granrud G, Sharkey P, Krejci J, Larson T, Erlien D, Berry D, Hodges M (1986) Pharmacodynamics and side effects of flecainide acetate. Clin Pharmacol Ther 40:101?107","journal-title":"Clin Pharmacol Ther"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00003495-199855030-00002","volume":"55","author":"IC Gelder Van","year":"1998","unstructured":"Van Gelder IC, Br\u00fcggeman J, Crijns HJGM (1998) Current treatment recommendations in antiarrhythmic therapy. Drugs 55:331?346","journal-title":"Drugs"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00007691-198911000-00017","volume":"6","author":"L Lie-A-Huen","year":"1989","unstructured":"Lie-A-Huen L, Stuurman RM, IJdenberg FN, Kingma JH, Meijer DKF (1989) High performance liquid chromatographic assay of flecainide and its enantiomers in serum. Ther Drug Monit 6:708?712","journal-title":"Ther Drug Monit"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/jps.2600740724","volume":"74","author":"JH Proost","year":"1985","unstructured":"Proost JH (1985) Wagner?s exact Loo-Riegelman equation: the need for a criterion to choose between the linear and logarithmic trapezoidal rule. J Pharm Sci 74:793?794","journal-title":"J Pharm Sci"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF00278588","volume":"38","author":"L Lie-A-Huen","year":"1990","unstructured":"Lie-A-Huen L, Proost JH, Kingma JH, Meijer DKF (1990) Absorption kinetics of oral and rectal flecainide in healthy subjects. Eur J Clin Pharmacol 38:595?598","journal-title":"Eur J Clin Pharmacol"},{"key":"CR12","unstructured":"Proost JH (1987) Critical evaluation of the determination of bioavailability by numerical deconvolution. Thesis, University of Groningen, The Netherlands"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00606431","volume":"22","author":"P Chennavasin","year":"1982","unstructured":"Chennavasin P, Brater DC (1982) Aminoglycoside dosage adjustment in renal failure: a hand-held calculator program. Eur J Clin Pharmacol 22:91?94","journal-title":"Eur J Clin Pharmacol"},{"key":"CR14","volume-title":"Numerical recipes","author":"WH Press","year":"1986","unstructured":"Press WH, Flennery BP, Teukolsky SA, Vetterling WT (1986) Numerical recipes. Cambridge University Press, Cambridge"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/10543409508835104","volume":"5","author":"F Mentr\u00e9","year":"1995","unstructured":"Mentr\u00e9 F, Gomeni R (1995) A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics. J Biopharm Stat 5:141?158","journal-title":"J Biopharm Stat"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/BF02353520","volume":"24","author":"JE Bennett","year":"1996","unstructured":"Bennett JE, Wakefield JC (1996) A comparison of a Bayesian population method with two methods as implemented in commercially available software. J Pharmacokinet Biopharm 24:403?432","journal-title":"J Pharmacokinet Biopharm"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00542167","volume":"27","author":"R Baeyens","year":"1984","unstructured":"Baeyens R, Reyntjens A, Verlinden M (1984) Cisapride accelerates gastric emptying and mouth-to-caecum transit of a barium meal. Eur J Clin Pharmacol 27:315?318","journal-title":"Eur J Clin Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2036.1987.tb00629.x","volume":"1","author":"B Kresvsky","year":"1987","unstructured":"Kresvsky B, Malmud LS, Maurer AH, Somers MB, Siegel JA, Fisher RS (1987) The effect of oral cisapride on colonic transit. Aliment Pharmacol Ther 1:293?304","journal-title":"Aliment Pharmacol Ther"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2125.1998.00706.x","volume":"45","author":"VHM Deneer","year":"1998","unstructured":"Deneer VHM, Lie-A-Huen L, Kingma JH, Proost JH, Kelder JC, Brouwers JRBJ (1998) Absorption kinetics of oral sotalol combined with cisapride and sublingual sotalol in healthy subjects. Br J Clin Pharmacol 45:485?490","journal-title":"Br J Clin Pharmacol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/bja\/67.3.302","volume":"67","author":"DJ Rowbothan","year":"1991","unstructured":"Rowbothan DJ, Milligan K, McHugh P (1991) Effect of single doses of cisapride and ranitidine administered simultaneously on plasma concentrations of cisapride and ranitidine. Br J Anaesth 67:302?305","journal-title":"Br J Anaesth"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00614304","volume":"30","author":"DN Bateman","year":"1986","unstructured":"Bateman DN (1986) The action of cisapride on gastric emptying and the pharmacodynamics and pharmacokinetics of oral diazepam. Eur J Clin Pharmacol 30:205?208","journal-title":"Eur J Clin Pharmacol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007691-198907000-00007","volume":"11","author":"W Kirch","year":"1989","unstructured":"Kirch W, Janisch HD, Ohnhaus EE, Van Peer A (1989) Cisapride-cimetidine interaction: enhanced cisapride bioavailability and accelerated cimetidine absorption. Ther Drug Monit 11:411?414","journal-title":"Ther Drug Monit"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00278493","volume":"42","author":"DJ Rowbothan","year":"1992","unstructured":"Rowbothan DJ, Parnacott S, Nimmo WS (1992) No effect of cisapride on paracetamol absorption after oral simultaneous administration. Eur J Clin Pharmacol 42:235?236","journal-title":"Eur J Clin Pharmacol"},{"key":"CR24","first-page":"236","volume":"12","author":"Organisation World Health","year":"1998","unstructured":"World Health Organisation (1998) Cisapride: new contraindications. WHO Drug information 12:236","journal-title":"WHO Drug information"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/clpt.1994.26","volume":"55","author":"C Funck-Brentano","year":"1994","unstructured":"Funck-Brentano C, Becquemont L, Kroemer HK, Buhl K, Knebel NG, Eichelbaum M, Jaillon P (1994) Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: contribution of genetic factors, dose-dependent clearance and interaction with amiodarone. Clin Pharmacol Ther 55:256?269","journal-title":"Clin Pharmacol Ther"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/clpt.1989.73","volume":"45","author":"G Mikus","year":"1989","unstructured":"Mikus G, Gross AS, Beckmann J, Hertrampf R, Gundert-Remy U, Eichelbaum M (1989) The influence of the sparteine\/debrisoquin phenotype on the disposition of flecainide. Clin Pharmacol Ther 45:562?576","journal-title":"Clin Pharmacol Ther"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/oxfordjournals.eurheartj.a062553","volume":"9","author":"HJGM Crijns","year":"1988","unstructured":"Crijns HJGM, Van Wijk LM, Van Gilst WH, Kingma JH, Van Gelder IC, Lie KI (1988) Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimes. Eur Heart J 9:634?638","journal-title":"Eur Heart J"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/clpt.1993.9","volume":"53","author":"R Padrini","year":"1993","unstructured":"Padrini R, Piovan D, Busa M, Al-Bunni M, Maiolino P, Ferrari M (1993) Pharmacodynamic variability of flecainide assessed by QRS changes. Clin Pharmacol Ther 53:59?64","journal-title":"Clin Pharmacol Ther"},{"key":"CR29","first-page":"211","volume":"XIII","author":"G Boriani","year":"1993","unstructured":"Boriani G, Capucci A, Strocchi E, Cavilla R, Santarelli A, Biffi M, Maganai B (1993) Flecainide acetate: concentration-response relationships for antiarrhythmic and electrocardiographic effects. Int J Clin Pharm Res XIII:211?219","journal-title":"Int J Clin Pharm Res"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9149(92)91392-H","volume":"70","author":"A Capucci","year":"1992","unstructured":"Capucci A, Lenzi T, Boriani G, Trisolino G, Binetti N, Cavazza M, Fontana G, Magnani B (1992) Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 70:69?72","journal-title":"Am J Cardiol"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0002-9149(94)90915-6","volume":"74","author":"A Capucci","year":"1994","unstructured":"Capucci A, Boriani G, Botto GL, Lenzi T, Rubino I, Falcone C, Trisolino G, Della Casa S, Binetti N, Cavazza M, Sanguinetti M, Magnani B (1994) Conversion of recent onset atrial fibrillation by a single oral loading dose of propafenone or flecainide. Am J Cardiol 74:503?505","journal-title":"Am J Cardiol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0831-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-004-0831-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0831-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:41:34Z","timestamp":1558701694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-004-0831-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,16]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s00228-004-0831-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,16]]}}}